15.11.24
Dawn's reflection: hope from Tigem research
The child, born with mucopolysaccharidosis type 6, was treated with gene therapy in 2020 and to date her liver is able to produce the missing enzyme that causes the disease.
11.10.24
A hope twelve thousand kilometres long
The story of Amari, who came from the small Caribbean Island of Trinidad to Milan to receive gene therapy for his rare genetic disorder of the immune system.
02.08.24
Violet's story: between research and outreach
The Canadian girl was born with mucopolysaccharidosis type 6. With help from the Isaac Foundation, she received important therapies in her country and participated in Italy in the trial developed by the Telethon Institute of Genetics and Medicine.
18.09.26
In vivo lentiviral gene therapy for methylmalonic acidemia moves towards the clinic
GENE202 is an in vivo lentiviral gene therapy for methylmalonic acidemia developed by SR-Tiget and Genespire and now moving towards clinical testing.
10.09.26
HITI genome editing for damaged liver tissue: towards stable therapies for genetic liver diseases
TIGEM researchers are studying HITI genome editing to develop stable and durable treatments for genetic diseases affecting damaged liver tissue.
02.09.26
Doctor and researcher: the dual career of a Physician Scientist
What does a Physician Scientist do, and how do they combine clinical care and laboratory research? Daniele Canarutto describes his career at SR-Tiget.
